Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22608338 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed A Phase I Study to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics of GSK2118436 in Subjects With Solid Tumors
Condition: Cancer
Interventions: Drug: GSK2118436;   Drug: Midazolam

Indicates status has not been verified in more than two years